These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2716804)

  • 1. Regression of Barrett's epithelium with omeprazole.
    Deviere J; Buset M; Dumonceau JM; Rickaert F; Cremer M
    N Engl J Med; 1989 Jun; 320(22):1497-8. PubMed ID: 2716804
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus.
    Fiorucci S; Santucci L; Farroni F; Pelli MA; Morelli A
    Am J Gastroenterol; 1989 Oct; 84(10):1263-7. PubMed ID: 2801676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barrett's ulcer: the clinical significance today.
    Komorowski RA; Hogan WJ; Chausow DD
    Am J Gastroenterol; 1996 Nov; 91(11):2310-3. PubMed ID: 8931408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole and Barrett's regression: is asymptomatic good enough?
    Krueger KJ; DiPalma JA
    Am J Gastroenterol; 1997 Jan; 92(1):177-8. PubMed ID: 8995971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Healing of esophageal ulcer after treatment with omeprazole in a patient with scleroderma and Barrett's esophagus].
    Fiorucci S; Santucci L; Bassotti G; Pelli MA; Morelli A
    Medicina (Firenze); 1988; 8(3):306-9. PubMed ID: 3231041
    [No Abstract]   [Full Text] [Related]  

  • 8. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC; Busnello JV; Saul C; Toneloto EB; Lopes CV; Rynkowski CB; Blaya C
    Am J Gastroenterol; 2000 Jul; 95(7):1661-8. PubMed ID: 10925965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Argon plasma coagulation for non-dysplastic Barrett's epithelium: a hard act to follow.
    Bozymski EM
    Am J Gastroenterol; 2007 May; 102(5):1128-9; author reply 1129-30. PubMed ID: 17489788
    [No Abstract]   [Full Text] [Related]  

  • 10. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.
    Luman W; Lessels AM; Palmer KR
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):627-30. PubMed ID: 8853248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of omeprazole in patients with Barrett's oesophagus.
    Scott LD; Sellin JH
    Aliment Pharmacol Ther; 1994 Aug; 8(4):473. PubMed ID: 7986975
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus.
    Fass R; Garewal HS; Hayden CW; Ramsey L; Sampliner RE
    Gastrointest Endosc; 2001 Jun; 53(7):711-6. PubMed ID: 11375576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complete regression of Barrett's esophagus after drug therapy].
    Pasqualini M; Farina PG; Livorti M; Petrogalli F; Romanelli R; Schenardi C
    G Chir; 1995 Mar; 16(3):113-5. PubMed ID: 7547122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
    Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
    Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
    Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
    Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Barrett's esophagus and omeprazole].
    Encinas Sotillos A; Romero Ganuza FJ; Hernández Navarrete C; Cabrerizo Puente A
    Rev Clin Esp; 1991 May; 188(9):484. PubMed ID: 1896599
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term follow-up and factors predictive of recurrence in Barrett's esophagus treated by argon plasma coagulation and acid suppression.
    Kahaleh M; Van Laethem JL; Nagy N; Cremer M; Devière J
    Endoscopy; 2002 Dec; 34(12):950-5. PubMed ID: 12471537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.
    Katzka DA; Castell DO
    Am J Gastroenterol; 1994 Jul; 89(7):989-91. PubMed ID: 8017396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.